Your browser doesn't support javascript.
loading
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan, David W; Yung, Mingo Mh; Chan, Yau-Sang; Xuan, Yang; Yang, Huijuan; Xu, Dakang; Zhan, Jin-Biao; Chan, Karen Kl; Ng, Tzi-Bun; Ngan, Hextan Ys.
Afiliação
  • Chan DW; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: dwchan@hku.hk.
  • Yung MM; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  • Chan YS; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  • Xuan Y; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  • Yang H; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, PR China.
  • Xu D; Faculty of Medical Laboratory Science, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, PR China.
  • Zhan JB; Department of Biochemistry, Zhejiang University School of Medicine, 866 Yuhangtang Road, Zijingang Campus, Hangzhou, Zhejiang, 310058, PR China.
  • Chan KK; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  • Ng TB; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Ngan HY; Department of Obstetrics & Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: hysngan@hku.hk.
Pharmacol Res ; 161: 105157, 2020 11.
Article em En | MEDLINE | ID: mdl-32814169
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Momordica charantia / Metabolismo Energético / Proteínas Inativadoras de Ribossomos Tipo 2 / Ferroptose / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Momordica charantia / Metabolismo Energético / Proteínas Inativadoras de Ribossomos Tipo 2 / Ferroptose / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article